News

ARCA biopharma, Inc., a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies for cardiovascular diseases, announced that clinical data evaluating Gencaro™ (bucindolol hydrochloride) as...

Preventice Solutions announced the publication of real-world data further validating BeatLogic® deep learning models designed to detect and classify multiple levels of data on heart rhythms gathered using BodyGuardian® remote cardiac...

PhysIQ, the Department of Defense, and The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF), in conjunction with the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense...

New guidance for optimizing patient outcomes through state-of-the-art care WASHINGTON, DC, May 5, 2020—Today, the Heart Rhythm Society (HRS) released a white paper announcing the rationale and core components for Atrial Fibrillation (AF)...

Use of automatic selfie videos to monitor pulse and heart rhythm may offer an effortless, always-on alternative to wearable devices WASHINGTON, DC, May 5, 2020—A new study leverages AI-based technology to offer a contactless monitoring...

Results indicate patients at high-risk for cardiac arrest overall show low use of potentially life-saving implantable cardioverter defibrillators WASHINGTON, D.C., May 5, 2020–Results of a clinical trial released today show stark disparities...

New study aims to address the myths and anxiety around caffeine consumption among heart rhythm patients WASHINGTON, D.C., May 5, 2020–A new study reveals that drinking a couple of daily cups of coffee does not lead to a greater risk of...

AliveCor, the leader in AI-based personal ECG technology and provider of enterprise cardiology solutions, announced a strategic collaboration with the Clifford Lab at Emory University School of Medicine, and the Georgia Institute of...

Abbott announced it has received CE Mark for the new Gallant™ implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) devices, bringing the most advanced heart rhythm management capabilities...

Fitbit launched the Fitbit Heart Study, its first large-scale, virtual study to validate the use of its wearable technology to identify episodes of irregular heart rhythm suggestive of atrial fibrillation (AFib), the most common form of heart...